"Promising Blood Test for Early Pancreatic Cancer Detection"
A new blood test has shown promise in detecting early-stage pancreatic cancer with up to 97% accuracy by identifying a genetic "signature" of the disease through the presence of specific RNA particles and DNA markers. The test, which outperformed the established marker CA 19-9, detected 93% of pancreatic cancers in U.S. participants and showed potential for early-stage disease detection. While more research is needed for validation, the findings offer hope for improved early detection of this often fatal malignancy.